Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - New York Stock Exchange, Inc. - FR0013467479 - Common Stock - Currency: USD

9.3  -0.09 (-0.96%)

After market: 9.3 0 (0%)

Fundamental Rating

5

Overall CSTM gets a fundamental rating of 5 out of 10. We evaluated CSTM against 152 industry peers in the Metals & Mining industry. While CSTM is still in line with the averages on profitability rating, there are concerns on its financial health. CSTM may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CSTM was profitable.
In the past year CSTM had a positive cash flow from operations.
Of the past 5 years CSTM 4 years were profitable.
CSTM had a positive operating cash flow in each of the past 5 years.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.06%, CSTM is in the better half of the industry, outperforming 67.76% of the companies in the same industry.
CSTM has a better Return On Equity (10.91%) than 81.58% of its industry peers.
The Return On Invested Capital of CSTM (6.72%) is better than 70.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSTM is in line with the industry average of 8.57%.
Industry RankSector Rank
ROA 2.06%
ROE 10.91%
ROIC 6.72%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

With a decent Profit Margin value of 1.48%, CSTM is doing good in the industry, outperforming 61.84% of the companies in the same industry.
In the last couple of years the Profit Margin of CSTM has declined.
CSTM has a Operating Margin (4.18%) which is comparable to the rest of the industry.
CSTM's Operating Margin has declined in the last couple of years.
CSTM's Gross Margin of 9.46% is in line compared to the rest of the industry. CSTM outperforms 40.13% of its industry peers.
CSTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.18%
PM (TTM) 1.48%
GM 9.46%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CSTM is creating some value.
Compared to 1 year ago, CSTM has less shares outstanding
Compared to 5 years ago, CSTM has more shares outstanding
The debt/assets ratio for CSTM is higher compared to a year ago.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CSTM has an Altman-Z score of 2.02. This is not the best score and indicates that CSTM is in the grey zone with still only limited risk for bankruptcy at the moment.
CSTM's Altman-Z score of 2.02 is in line compared to the rest of the industry. CSTM outperforms 46.71% of its industry peers.
The Debt to FCF ratio of CSTM is 17.86, which is on the high side as it means it would take CSTM, 17.86 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CSTM (17.86) is better than 61.84% of its industry peers.
A Debt/Equity ratio of 1.97 is on the high side and indicates that CSTM has dependencies on debt financing.
CSTM's Debt to Equity ratio of 1.97 is on the low side compared to the rest of the industry. CSTM is outperformed by 88.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 17.86
Altman-Z 2.02
ROIC/WACC0.83
WACC8.09%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.28 indicates that CSTM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.28, CSTM is not doing good in the industry: 77.63% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that CSTM may have some problems paying its short term obligations.
CSTM has a worse Quick ratio (0.52) than 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.52
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for CSTM have decreased strongly by -51.65% in the last year.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
Looking at the last year, CSTM shows a decrease in Revenue. The Revenue has decreased by -6.27% in the last year.
Measured over the past years, CSTM shows a small growth in Revenue. The Revenue has been growing by 4.43% on average per year.
EPS 1Y (TTM)-51.65%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-555.71%
Revenue 1Y (TTM)-6.27%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%0.06%

3.2 Future

The Earnings Per Share is expected to grow by 103.89% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.75% on average over the next years. This is quite good.
EPS Next Y144.45%
EPS Next 2Y103.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.89%
Revenue Next 2Y13.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

8

4. Valuation

4.1 Price/Earnings Ratio

CSTM is valuated rather expensively with a Price/Earnings ratio of 22.68.
Based on the Price/Earnings ratio, CSTM is valued a bit cheaper than the industry average as 69.74% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CSTM to the average of the S&P500 Index (28.79), we can say CSTM is valued slightly cheaper.
CSTM is valuated reasonably with a Price/Forward Earnings ratio of 9.26.
CSTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSTM is cheaper than 88.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (21.38), we can say CSTM is valued rather cheaply.
Industry RankSector Rank
PE 22.68
Fwd PE 9.26
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSTM is valued cheaper than 87.50% of the companies in the same industry.
CSTM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CSTM is cheaper than 89.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.93
EV/EBITDA 5.19
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CSTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CSTM may justify a higher PE ratio.
A more expensive valuation may be justified as CSTM's earnings are expected to grow with 103.89% in the coming years.
PEG (NY)0.16
PEG (5Y)6.95
EPS Next 2Y103.89%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONSTELLIUM SE

NYSE:CSTM (4/25/2025, 8:04:01 PM)

After market: 9.3 0 (0%)

9.3

-0.09 (-0.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners93.48%
Inst Owner Change0.34%
Ins Owners1.48%
Ins Owner ChangeN/A
Market Cap1.33B
Analysts84
Price Target19.13 (105.7%)
Short Float %1.17%
Short Ratio0.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.21%
Min EPS beat(2)-61.15%
Max EPS beat(2)10.73%
EPS beat(4)1
Avg EPS beat(4)-46.37%
Min EPS beat(4)-76.87%
Max EPS beat(4)10.73%
EPS beat(8)1
Avg EPS beat(8)-40.69%
EPS beat(12)3
Avg EPS beat(12)2.71%
EPS beat(16)7
Avg EPS beat(16)138.22%
Revenue beat(2)0
Avg Revenue beat(2)-8.28%
Min Revenue beat(2)-9.9%
Max Revenue beat(2)-6.66%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)5.74%
Revenue beat(8)2
Avg Revenue beat(8)-2.19%
Revenue beat(12)6
Avg Revenue beat(12)0.32%
Revenue beat(16)10
Avg Revenue beat(16)1.19%
PT rev (1m)0%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-67.64%
EPS NY rev (1m)-24.62%
EPS NY rev (3m)-27.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)13.42%
Valuation
Industry RankSector Rank
PE 22.68
Fwd PE 9.26
P/S 0.18
P/FCF 11.93
P/OCF 2.65
P/B 1.36
P/tB 3.08
EV/EBITDA 5.19
EPS(TTM)0.41
EY4.41%
EPS(NY)1
Fwd EY10.8%
FCF(TTM)0.78
FCFY8.38%
OCF(TTM)3.51
OCFY37.76%
SpS50.63
BVpS6.86
TBVpS3.02
PEG (NY)0.16
PEG (5Y)6.95
Profitability
Industry RankSector Rank
ROA 2.06%
ROE 10.91%
ROCE 8.5%
ROIC 6.72%
ROICexc 7.02%
ROICexgc 8.36%
OM 4.18%
PM (TTM) 1.48%
GM 9.46%
FCFM 1.54%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score5
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 17.86
Debt/EBITDA 3.15
Cap/Depr 125.82%
Cap/Sales 5.4%
Interest Coverage 2.51
Cash Conversion 81.93%
Profit Quality 104.25%
Current Ratio 1.28
Quick Ratio 0.52
Altman-Z 2.02
F-Score5
WACC8.09%
ROIC/WACC0.83
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.65%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-555.71%
EPS Next Y144.45%
EPS Next 2Y103.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.27%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%0.06%
Revenue Next Year18.89%
Revenue Next 2Y13.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.81%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year106.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.78%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%